1 active not recruiting, 1 completed, 1 unknown. 3 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Active not recruiting 1, Completed 1, Unknown 1 |
Follow Castration-resistant Prostate Cancer: new trials by email Literature Review of Castration-resistant Prostate Cancer trials Research Report on Castration-resistant Prostate Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC Enhanced autologous PSMA-CAR T - Metastatic Castration-resistant Prostate Cancer, Castration-resistant Prostate Cancer | Early Phase 1 | Active not recruiting | Shanghai Changzheng Hospital | 18 | 2024-03-03 | 2026-07-23 |
| Testosterone Therapy in Castration Resistant Prostate Cancer Transdermal Testosterone, Standard of Care, Enzalutamide - Prostate Cancer, Castration-Resistant Prostate Cancer | Early Phase 1 | Completed | University of Colorado, Denver | 30 | 2019-01-18 | 2025-11-06 |
| Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer Gadoxetate Sodium - Cancer of the Prostate, Castration-resistant Prostate Cancer | Early Phase 1 | Unknown | University of Cincinnati | 50 | 2018-01-02 | 2019-05-23 |
Prostatic Neoplasms (2) · Neoplasm Metastasis (1)
Neoplasms (3) · Genital Diseases (2) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Male Urogenital Diseases (2) · Neoplasms by Site (2) · Prostatic Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Standard of Care (1) · enzalutamide (1)
Shanghai Changzheng Hospital (1) · University of Cincinnati (1) · University of Colorado, Denver (1)
United States (2) · China (1)
Laura Graham, MD (1) · Sadhna Verma, MD (1)